A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With Primary Sclerosing Cholangitis
Abroad (travel likely)RecruitingPHASE3
Conditions
Primary Sclerosing Cholangitis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Arizona Liver Health, Chandler, Arizona, United States
American Research Corporation at The Texas Liver Institute, San Antonio, Texas, United States
Study leads
Ipsen Medical Director
Study Director
Ipsen